review

Showing 4 posts of 4 posts found.

Medicinal cannabis in a laboratory

Review signals step towards legalisation of medicinal cannabis in UK

July 4, 2018
Research and Development England, cannabis, pharma, review, thc

England’s Chief Medical Officer Dame Sally Davies has concluded that there is “conclusive evidence” that cannabis is medically beneficial for …

clinical_trial_3

EMA to revise clinical trial guidelines

May 27, 2016
Medical Communications, Research and Development EMA, Guidelines, amend, clinical trial, review, revise

The European Medicines Agency (EMA) has announced that it will conduct a review in an attempt to revise its guidelines …

EMA to review Pfizer’s Xeljanz for patients with rheumatoid arthritis

March 24, 2016
Research and Development, Sales and Marketing EMA, Pfizer, Xeljanz, approval, authorisation, marketing, review, rheumatoid arthritis

Pfizer (NYSE: PFE) has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application (MAA) …

2008: A year in the life of UK pharma

December 31, 2008
Research and Development, Sales and Marketing 2008, YIR, patients, pharma, review, social networking, year in review

  Patient power proves decisive in battle for accessSocial networking helped a new breed of informed patient advocates win the …

The Gateway to Local Adoption Series

Latest content